Synthetic glycopeptide-based delivery systems for systemic gene targeting to hepatocytes

Pharmaceutical Research

Volumn 17, Issue 4, 2000, Pages 451-459

  Anwer, Khursheed ^a   Logan, Mark ^a   Tagliaferri, Frank ^a   Wadhwa, Manpreet ^a   Monera, Oscar ^a   Tung, Ching Hsuan ^a   Chen, Wei ^a   Leonard, Pat ^a   French, Martha ^a   Proctor, Belinda ^a   Wilson, Elizabeth ^a   Singhal, Arun ^a   Rolland, Alain ^a  

^a Urigen Pharmaceuticals Inc   (United States)

Author keywords

Gene delivery system; Gene targeting; Glycopeptide; Hepatocyte; Transfection efficiency

Indexed keywords

GLYCOPEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG DNA BINDING; DRUG SYNTHESIS; DRUG TOLERABILITY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INJECTION; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENE EXPRESSION; GENE TARGETING; GLYCOPEPTIDES; LIVER; MICE; MOLECULAR SEQUENCE DATA; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034048198     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007533121682     Document Type: Article

References (21)

1. 1. D. K. F. Meijer and G. Molema. Targeting of drugs to the liver. Semi. Liver Disease 15:202-256 (1995).
2. 2. F. D. Ledley, R. M. Adams, H. E. Soriano, G. Darlington, M. Finegold, R. Lanford, D. Carey, D. Lewis, P. A. Baley, S. Rothenberg, M. Kay, M. Brandt, R. Moen, W. F. Wnderson, P. Whitington, W. Pokorny, and S. L. C. Woo. Development of a clinical protocol for hepatic gene transfer: Lessons learned in preclinical studies. Ped. Res. 33:313-320 (1993).
3. 3. A. P. Rolland. From Genes to Gene Medicines: Recent advances in non-viral gene delivery. Crit. Rev. Ther. Carrier Systems 15:143-198 (1998).
4. 4. R. J. Stockert. The asialoglycoprotein receptor: Relationships between structure, function, and expression. Physiol. Rev. 76:591-609 (1995).
5. 5. G. Y. Wu, J. M. Wilson, F. Shalaby, M. Grossman, D. A. Shafritz, and C. H. Wu. Receptor-mediated gene delivery in vivo. J. Biol. Chem. 266:14338-14342 (1991).
6. 6. G. Y. Wu, and C. H. Wu. Liver-directed gene delivery. Adv. Drug Del. Rev. 12:159-167 (1993).
7. 7. J. Frese, C. H. Wu, and G. Y. Wu. Targeting of genes to the liver with glycoprotein carrier. Adv. Drug Del. Rev. 14:137-152 (1994).
8. 8. L. C. Smith, J. Duguid, M. S. Wadhwa, M. J. Logan, C. H. Tung, V. Edwards, and J. T. Sparrow. Synthetic peptide-based DNA complexes for nonviral gene delivery. Adv. Drug. Deliv. Rev. 30:115-131 (1998).
9. 9. S. Gottschalk, J. T. Sparrow, J. Hauer, M. P. Mims, F. E. Leland, S. L. Woo, and L. C. Smith. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther. 3:448-457 (1996).
10. 10. M. Nishikawa, S. Takemura, Y. Takakura, and M. Hashida. Targeted delivery of plasmid DNA to hepatocytes in vivo: Optimization of the pharmacokinetics of plasmid DNA/galactosylated poly (L-lysine) complexes by controlling their physicochemical properties. J. Pharmacol. Exp. Ther. 287:408-415 (1998).
11. 11. J. G. Duguid, C. Li, M. Shi, M. C. Logan, H. Alila, A. Rolland, E. Tomlinson, J. T. Sparrow, and L. C. Smith. A physiochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy. Biophys. J. 74, 2802-2814, 1998.
12. 12. G. Barany and R. B. Marrifield. Solid phase peptide synthesis. In The Peptides: Analysis, Synthesis, Biology, Acad. Press, New York (1980).
13. th American Peptide Symposium". R. S. Hodges and J. D. Smith (eds.), Escom, Leiden, 1994, pp. 113.
14. 14. Haensler, J. and Schuber, F. Preparation of neo-galactosylated liposomes and their interaction with mouse peritoneal macrophages. Biochim. Biophy. Acta 946:95-105 (1988).
15. 15. Otvos, T., Wroblewski, K., Kollat, E., Perczel, A., Hollosi, M., Fasman, G. D., Ertl, H. C. J. and Thurin, J. Coupling strategies in solid-phase synthesis of glycopeptides. Peptide Res. 2:362-366 (1989).
16. 16. K. Anwer, K. A. Earle, M. Shi, J. Wang, R. J. Mumper, B. Proctor, K. Jansa, H. C. Ledebur, S. Davis, W. Eaglstein, and A. P. Rolland. Synergistic effect of formulated plasmid and needle-free injection device for genetic vaccines. Pharm. Res. 16:889-895 (1999).
17. 17. A. L. Schwartz, S. E. Fridovich, and H. F. Lodish. Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line. J. Biol. Chem. 257:4230-4237 (1982).
18. 18. T. Kawabata, and L. Packer. Alpha-lipoate can protect against glycation of serum albumin, but not low density lipoprotein. Biochem. Biophys. Res. Commun. 203:99-104 (1994).
19. 19. S. I. Michael, and D. T. Curiel. Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. Gene Ther. 1:223-232 (1994).
20. 20. F. Liu, Y. K. Song, and D. Liu. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6:1258-1266 (1999).
21. 21. G. Zhang, V. Budker, and J. A. Wolff. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10:1735-1737 (1999).